Deciphering the mechanism of action of VP343, an antileishmanial drug candidate, in Leishmania infantum
Summary: Antileishmanial chemotherapy is currently limited due to severe toxic side effects and drug resistance. Hence, new antileishmanial compounds based on alternative approaches, mainly to avoid the emergence of drug resistance, are needed. The present work aims to decipher the mechanism of acti...
Κύριοι συγγραφείς: | Sameh Obeid, Eloisa Berbel-Manaia, Valérie Nicolas, Indira Dennemont, Julien Barbier, Jean-Christophe Cintrat, Daniel Gillet, Philippe M. Loiseau, Sébastien Pomel |
---|---|
Μορφή: | Άρθρο |
Γλώσσα: | English |
Έκδοση: |
Elsevier
2023-11-01
|
Σειρά: | iScience |
Θέματα: | |
Διαθέσιμο Online: | http://www.sciencedirect.com/science/article/pii/S2589004223022216 |
Παρόμοια τεκμήρια
-
Antileishmanial activity of terpenylquinones on Leishmania infantum and their effects on Leishmania topoisomerase IB
ανά: Yolanda Pérez-Pertejo, κ.ά.
Έκδοση: (2019-12-01) -
Leishmania infantum asymptomatic infection in inflammatory bowel disease patients under anti-TNF therapy
ανά: M. Carmen Guillén, κ.ά.
Έκδοση: (2020-05-01) -
Leishmania amazonensis sabotages host cell SUMOylation for intracellular survival
ανά: Kendi Okuda, κ.ά.
Έκδοση: (2022-09-01) -
Antileishmanial Activity of BNIPDaoct- and BNIPDanon-loaded Emulsomes on Leishmania infantum Parasites
ανά: Zeynep Islek, κ.ά.
Έκδοση: (2022-01-01) -
The different impact of drug-resistant Leishmania on the transcription programs activated in neutrophils
ανά: Míriam Díaz-Varela, κ.ά.
Έκδοση: (2024-05-01)